Marcelo Sobral-Leite

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Research square

Oncoimmunology

Antoni van Leeuwenhoek Nederlands Kanker Instituut

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Antoni van Leeuwenhoek Nederlands Kanker Instituut Nov 06 2013

Netherlands

PhD candidate :: Molecular Pathology

Publications

Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman Hagos, Joyce Sanders, Mathilde Almekinders, Lindy L Visser, Emma Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Yinyin Yuan, null null, Renee Menezes, Esther Lips, Jelle Wesseling
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer. Research square (2023)
Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman Hagos, Joyce Sanders, Mathilde Almekinders, Lindy L Visser, Emma Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Yinyin Yuan, Grand Challenge Precision Consortium, Renee Menezes, Esther Lips, Jelle Wesseling
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer. Research square (2023)
Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman Hagos, Joyce Sanders, Mathilde Almekinders, Lindy L Visser, Emma Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Yinyin Yuan, Grand Challenge Precision Consortium, Renee Menezes, Esther Lips, Jelle Wesseling
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer. Research square (2023)
Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman Hagos, Joyce Sanders, Mathilde Almekinders, Lindy L Visser, Emma Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Yinyin Yuan, null null, Renee Menezes, Esther Lips, Jelle Wesseling
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer. Research square (2023)
Marcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, Xenia Melillo, Noomie Lam, Brandi de Bruijn, Yeman Hagos, Joyce Sanders, Mathilde Almekinders, Lindy L Visser, Emma Groen, Petra Kristel, Caner Ercan, Leyla Azarang, Yinyin Yuan, null null, Renee Menezes, Esther Lips, Jelle Wesseling
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer. Research square (2023)
Marcelo Sobral-Leite, Koen K van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K J Hooijer, Hugo Mark Horlings, Tesa M Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J van de Vijver, René Bernards, Irene L Andrulis, Marleen Kok, Karin E de Visser, Marjanka K Schmidt
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. Oncoimmunology 7 (12) (2018)

Marcelo Sobral-Leite.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marcelo Sobral-Leite